Emergency Use Licence for Covaxin: Bharat Bio submits all documents to WHO

Our Bureau Hyderabad | Updated on July 12, 2021

Bharat Biotech CMD Krishna Ella NAGARA GOPAL   -  NAGARA GOPAL

Bharat Biotech has submitted all documents required to grant Emergency Use Licence (EUL) for its Covid-19 vaccine Covaxin to the World Health Organisation (WHO).

The documents were submitted on July 9, 2021, Krishna Ella, Chairman & Managing Director, Bharat Biotech said in a social media post.

"The review process has now commenced with the expectation that we will receive EUL at the earliest, " Ella said.


Published on July 12, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like